Synthesis and biopharmaceutical characterisation of new poly(hydroxyethylaspartamide) copolymers as drug carriers

Biochimica et Biophysica Acta - General Subjects

Volumn 1528, Issue 2-3, 2001, Pages 177-186

  Caliceti, Paolo ^a   Quarta, Santina Maria ^a   Veronese, Francesco Maria ^a   Cavallaro, Gennara ^b   Pedone, Elisa ^b   Giammona, Gaetano ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Amphiphilic copolymer; Biodistribution; Pharmacokinetics; Polyaspartamide derivative; Polymeric carrier

Indexed keywords

COPOLYMER; DRUG CARRIER; ETHANOLAMINE; MACROGOL; MACROGOL 2000; MACROGOL 5000; POLY(HYDROXYETHYLASPARTAMIDE) COPOLYMER; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DESIGN; DRUG SYNTHESIS; INFRARED RADIATION; KIDNEY CLEARANCE; LIGHT SCATTERING; LIVER; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLID TUMOR; SPLEEN; TISSUE DISTRIBUTION;

ANIMALS; DRUG CARRIERS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; NEOPLASMS; PEPTIDES; POLYETHYLENE GLYCOLS; POLYMERS; SPECTROPHOTOMETRY, INFRARED; TISSUE DISTRIBUTION;

EID: 0035802323     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(01)00191-X     Document Type: Article

References (28)

1. Pendent drugs, release from polymers
2. Targetable polymeric drugs
3. Water soluble polymers in medicine
4. Block copolymer micelles as long-circulating drug vehicles
5. Polymeric micelles as new drug carriers
6. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size
7. Block copolymer micelles as vehicles for hydrophobic drugs
8. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl-l-aspartate) block copolymer micelles
9. Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline
10. Structure and design of polymeric surfactant-based drug delivery systems
11. Macromolecular systems for chemotherapy and resonance imaging
12. Drug polymer conjugates; potential for improved chemotherapy
13. Polymeric prodrugs: α,β-poly(N-2-hydroxyethyl)-dl-aspartamide as a macromolecular carrier for some non-steroidal antiinflammatory agents
14. Hydrophilic and hydrophobic polymeric derivatives of antiinflammatory agents such as Alclofenac, Ketoprofen and Ibuprofen
15. Pinocytosis of poly-α,β-(N-2-hydroxyethyl)-dl-aspartamide
16. Chemical stability and bioavailability of acyclovir coupled to α,β-poly(N-2-hydroxyethyl)-dl-aspartamide
17. Polymeric prodrug for release of an antitumoral agent by specific enzymes
18. Molecular characterisation of a α,β-poly[(hydroxyethyl)-dl-aspartamide] by light scattering and viscosimetric studies
19. Reaction of α,β-poly(N-2-hydroxyethyl)-dl-aspartamide with derivatives of carboxylic acid
20. Comparison of body distribution of poly(vinyl alcohol) with other water soluble polymer after intravenous administration
21. Stabilisation of substances in circulation
22. Biodegradable long-circulating polymeric nanospheres
23. Stealth MePEG-PLA nanoparticles avoid uptake by the mononuclear phagocyte system
24. Properties and reactivity of polysuccinimide
25. Synthesis of macromolecular prodrug of Procaine, Histamine and Isoniazid
26. Polymer conjugates for tumour targeting and intracytoplasmatic delivery. The EPR effect as a common gateway